Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.60 |
| ▸ | MAPT | P10636 | 7/20 | 0.60 |
| ▸ | LMNA | P02545 | 6/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.60 |
| ▸ | GAA | P10253 | 6/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 6/20 | 0.52 |
| ▸ | HTT | P42858 | 6/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 4/20 | 0.49 |
| ▸ | ASF1A | Q9Y294 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3079735 | 0.86 | KDM4E (0.58) | RAB9AKDM4EMAPTLMNASMN1; SMN2 | |
| SCHEMBL6711432 | 0.86 | KDM4E (0.58) | RAB9AKDM4EMAPTLMNASMN1; SMN2 | |
| SCHEMBL6493566 | 0.84 | RAB9A (0.59) | RAB9AKDM4EMAPTLMNASMN1; SMN2 | |
| SCHEMBL4807377 | 0.84 | KDM4E (0.56) | RAB9AKDM4EMAPTLMNASMN1; SMN2 | |
| SCHEMBL4807384 | 0.84 | KDM4E (0.56) | RAB9AKDM4EMAPTLMNASMN1; SMN2 | |
| SCHEMBL22903889 | 0.83 | RAB9A (0.50) | RAB9AKDM4EMAPTLMNASMN1; SMN2 | |
| SCHEMBL28170008 | 0.81 | PAX8 (0.58) | RAB9AKDM4EMAPTLMNASMN1; SMN2 | |
| SCHEMBL6504390 | 0.80 | CTH (0.57) | RAB9AKDM4EMAPTLMNASMN1; SMN2 | |
| SCHEMBL12858541 | 0.79 | RAB9A (0.69) | RAB9AKDM4EMAPTLMNASMN1; SMN2 | |
| SCHEMBL3146064 | 0.78 | MEN1 (0.65) | RAB9AKDM4EMAPTLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288258-A1 | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | DIANA GUY D | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288258-A1 | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | MAVS, HAVCR2, ZC3HAV1 | RAB9A 1478/4885KDM4E 3307/4885MAPT 2744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.